EBR Systems, Inc. (NONE.): R&D Expense

Annual figures by period end, from SEC filings.

$23.94M
Year ended 2025-12-31
$27.15M2023-12-31: $27.15M2024-12-31: $27.07M2025-12-31: $23.94M$23.94M
2023-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$23.94M-11.5%2026-03-18, From 2025-01-01
2024-12-31$27.07M-0.3%2026-03-18, From 2024-01-01
2023-12-31$27.15Mn/a2025-03-24, From 2023-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
EBR Systems, Inc. (NONE.)2025-12-31$23.94M-11.5%
Vycor Medical Inc (VYCO)2025-12-31$10.0K-35.0%
SeaStar Medical Holding Corp (ICU)2025-12-31$7.52M-17.4%
PetVivo Holdings, Inc. (PETV)2026-03-31$1.42M-10.6%
Femasys Inc (FEMY)2025-12-31$7.58M-7.8%
RenovoRx, Inc. (RNXT)2025-12-31$6.27M+4.0%
Sintx Technologies, Inc. (SINT)2025-12-31$4.59M-11.8%
QHSLab, Inc. (USAQ)2025-12-31$484.9K+64.7%
OSR Health, Inc. (OSRH)2025-12-31$318.4K+97.6%

Compare NONE., VYCO, ICU, PETV side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗